California Stem Cell, Inc. announced today that the U.S. Food and Drug Administration has approved the Company's application to begin a Phase III clinical trial exploring the potential of a cancer stem cell-based platform therapy to treat advanced metastatic melanoma.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131203005714&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131203005714&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment